Renninger Robert 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Renninger Robert（CIK 2037968）在 2 家公司共报告 8 笔 SEC Form 4 内部人交易（最近一笔 2026-03-05）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-03-05 | LeonaBio, Inc. (LONA) | CHIEF FINANCIAL OFFICER | 买入 | 3,900 | $0 |
| 2026-03-05 | LeonaBio, Inc. (LONA) | CHIEF FINANCIAL OFFICER | 卖出 | 906 | $4,865 |
| 2026-01-05 | Athira Pharma, Inc. (ATHA) | Chief Financial Officer | 买入 | 1,000 | $2,310 |
| 2026-01-05 | Athira Pharma, Inc. (ATHA) | Chief Financial Officer | 买入 | 1,236 | $0 |
| 2026-01-05 | Athira Pharma, Inc. (ATHA) | Chief Financial Officer | 卖出 | 297 | $2,043 |
| 2025-07-02 | Athira Pharma, Inc. (ATHA) | SVP, Finance and Accounting | 买入 | 10,000 | $2,300 |
| 2025-07-02 | Athira Pharma, Inc. (ATHA) | SVP, Finance and Accounting | 买入 | 12,359 | $0 |
| 2025-07-02 | Athira Pharma, Inc. (ATHA) | SVP, Finance and Accounting | 卖出 | 2,897 | $840 |
来源：SEC Form 4 申报文件 · 截至 2026-03-05